The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2023
DOI: 10.3389/fpubh.2023.1120926
|View full text |Cite
|
Sign up to set email alerts
|

Walking activity increases physical abilities and subjective health in people with seven different types of disabilities

Abstract: IntroductionPeople with disabilities have a great risk of physical inactivity, which causes several diseases, dependency, and long-term care. Walking helps to increase physical activity, which leads to better overall health and independence. However, less research attention has focused on walking for people with disabilities, and even fewer studies have been considered for different types of disabilities. The present study aimed to demonstrate how walking distance was associated with people with seven differen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
13
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2
2
1

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(13 citation statements)
references
References 56 publications
0
13
0
Order By: Relevance
“…By the end of 2022, the RAINBO Research Consortium has announced its new program for refining the adjuvant treatment in endometrial cancer based on molecular features 53 . An overarching research program consisted of four international studies: RED Trial, a phase III trial of p53 abnormal endometrial cancer cases that compares adjuvant chemoradiation followed by two years of olaparib immunotherapy versus radiotherapy alone.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…By the end of 2022, the RAINBO Research Consortium has announced its new program for refining the adjuvant treatment in endometrial cancer based on molecular features 53 . An overarching research program consisted of four international studies: RED Trial, a phase III trial of p53 abnormal endometrial cancer cases that compares adjuvant chemoradiation followed by two years of olaparib immunotherapy versus radiotherapy alone.…”
Section: Discussionmentioning
confidence: 99%
“…The main results of the RAINBO clinical program are expected to be announced by 2028. The shareholders aim to fill the void of whether molecular-directed adjuvant treatment is the more effective, less toxic, better quality of life provider than the current patient management principles for patients with endometrial cancer 53…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…By the end of 2022, the RAINBO Research Consortium has announced its new program for refining the adjuvant treatment in endometrial cancer based on molecular features 53 . An overarching research program consisted of four international studies: RED Trial, a phase III trial of p53 abnormal endometrial cancer cases that compares adjuvant chemoradiation followed by two years of olaparib immunotherapy versus radiotherapy alone.…”
Section: Discussionmentioning
confidence: 99%
“…The main results of the RAINBO clinical program are expected to be announced by 2028. The shareholders aim to fill the void of whether molecular-directed adjuvant treatment is the more effective, less toxic, better quality of life provider than the current patient management principles for patients with endometrial cancer 53…”
Section: Discussionmentioning
confidence: 99%